MedPath

Advanced Accelerator Applications USA, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

FDA:4

Drug Approvals

PLUVICTO

Approval Date
Jan 18, 2024
FDA

LOCAMETZ

Approval Date
Nov 8, 2023
FDA

NETSPOT

Approval Date
Oct 26, 2023
FDA

Lutathera

Approval Date
Mar 7, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.